10/2
11:20 am
biol
BIOLASE, Inc. (NASDAQ: BIOL) had its "speculative buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $0.40 price target on the stock.
High
Report
BIOLASE, Inc. (NASDAQ: BIOL) had its "speculative buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $0.40 price target on the stock.
10/2
11:20 am
biol
BIOLASE, Inc. (NASDAQ: BIOL) had its "speculative buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $0.40 price target on the stock.
High
Report
BIOLASE, Inc. (NASDAQ: BIOL) had its "speculative buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $0.40 price target on the stock.
10/2
10:13 am
biol
Rating for BIOL
High
Report
Rating for BIOL
10/2
10:13 am
biol
Rating for BIOL
High
Report
Rating for BIOL
9/3
06:21 am
biol
Rating for BIOL
Low
Report
Rating for BIOL